Freedom of Information request for emails regarding PFS caused by Dutasteride (FOI 22/633)
Published 27 March 2023
© Crown copyright 2023
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-9-may-2022/freedom-of-information-request-for-emails-regarding-pfs-caused-by-dutasteride-foi-22633
FOI 22/633
10th May 2022
Dear
Thank you for your FOI request dated 26th April.
Having searched our records, we can confirm that we do not hold any emails regarding PFS caused by Dutasteride except those relating to your query of 19th April.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division